FDA Drug Application (206099) for ONZETRA XSAIL by AVANIR PHARMS

Back to FDA Applications sponsored by AVANIR PHARMS

Application Number206099
Product Number001
FormPOWDER;INHALATION
DosageEQ 11MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameONZETRA XSAIL
Active IngredientSUMATRIPTAN SUCCINATE

Active IngredientCount
List of drugs with Active Ingredient SUMATRIPTAN4
List of drugs with Active Ingredient SUMATRIPTAN SUCCINATE10


Back to FDA Applications sponsored by AVANIR PHARMS